Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Paclitaxel | Oncology | LC/MS/MS | 50-10000 ng/mL | Dog Plasma |
| Paclitaxel | Oncology | LC/MS/MS | 5-5000 ng/mL | Human Sodium Heparinized Plasma |
| Paclitaxel | Oncology | LC/MS/MS | 5-2500 ng/mL | K2-EDTA human plasma |
| Pantoprazole | Gastrointestinal | LC/MS/MS | 20-4000 ng/mL | Human Lithium Heparinized Plasma |
| Pantoprazole | Gastrointestinal | HPLC/UV | 20-2000 ng/mL | Human EDTA Plasma |
| Pantoprazole | Gastrointestinal | LC/MS/MS | 20-4000 ng/mL | Human EDTA Plasma |
| Paricalcitol | Rheumatology | LC/MS/MS | 10-1000 pg/mL | Human EDTA Plasma |
| Paroxetine | Central Nervous System Agents | LC/MS/MS | 0.25-50 ng/mL | Human EDTA Plasma |
| Paroxetine | Central Nervous System Agents | LC/MS/MS | 100-15000 pg/mL | Human EDTA Plasma |
| Paroxetine | Central Nervous System Agents | LC/MS/MS | 0.1-30 ng/mL | Human K3 EDTA Plasma |
| Pegasys (Pegylated Interferon alpha 2a) | Respiratory | Elisa | 312.5-40000 pg/mL | Human Serum |
| Pemetrexed | Oncology | LC/MS/MS | 1-200 µg/mL | Human EDTA Plasma |
| Penciclovir | Infectious Disease | LC/MS/MS | 50-10000 ng/mL | Human EDTA Plasma |
| Pentazocine | Pain | LC/MS/MS | 5-800 ng/mL | Human Plasma |
| Pentoxifylline; Metabolite I; Metabolite V | Hematologic Agent | LC/MS/MS | 1-500 ng/mL; 2-1000 ng/mL; 3-1500 ng/mL | Human EDTA Plasma |
| Pentoxyfilline | Genitourinary | HPLC/UV | 10-400 ng/mL | Human Plasma |
| Pergolide | Central Nervous System Agents | LC/MS/MS | 2-50 pg/mL | Human EDTA Plasma |
| Perindopril; Perindoprilat | Cardiovascular | LC/MS/MS | 400-160000 pg/mL ; 100-40000 pg/mL | Human EDTA Plasma |
| Phenylbutazone | Pain | HPLC/UV | 0.1-50 µg/mL | Horse Plasma |
| Phenylephrine | Respiratory | LC/MS/MS | 2-400ng/mL | Monkey EDTA K2 Plasma |
| Phenylephrine free | Infectious Disease | LC/MS/MS | 10-2500 pg/mL | Human Plasma |
| Phenytoin | Central Nervous System Agents | LC/MS/MS | 25-2500 ng/mL | Human Plasma |
| Pinaverium | Gastrointestinal | LC/MS/MS | 5-2500 pg/mL | Human EDTA Plasma |
| Pioglitazone; Hydroxypioglitazone | Endocrinology | LC/MS/MS | 10-3000 ng/mL; 10-1500 ng/mL | Human EDTA Plasma |
| Pioglitazone; Hydroxypioglitazone; Ketopioglitazone | Endocrinology | LC/MS/MS | 10-2000 ng/mL; 20-2000 ng/mL; 4-800 ng/mL | Human EDTA Plasma |
| Piracetam | Central Nervous System Agents | LC/MS/MS | 0.5-5 µg/mL | Human EDTA plasma |
| Piretanide | Cardiovascular | LC/MS/MS | 0.5-300 ng/mL | Human EDTA Plasma |
| Pirlindole | Central Nervous System Agents | LC/MS/MS | 0.5-500 ng/mL | Human Plasma |
| Platinum (Free) | Oncology | ICP-MS | 5-1000ng/mL | Human EDTA K3 Plasma |
| Platinum (Total) | Oncology | ICP-MS | 5-1000ng/mL | Human EDTA K3 Plasma |
| Posaconazole | TBD | LC/MS/MS | 1-500 ng/mL | Human EDTA Plasma |
| Potassium | Miscellaneous | ICP-MS | 200-40000µg/mL | Human Urine |
| Pramipexole | Central Nervous System Agents | LC/MS/MS | 50-5000 pg/ml | Human EDTA Plasma |
| Pramipexole | Central Nervous System Agents | LC/MS/MS | 10.01-1004 pg/mL | Human EDTA Plasma |
| Pravastatin | Cardiovascular | LC/MS/MS | 0.4-200 ng/mL | Human EDTA Plasma |
| Pravastatin; 3-a-hydroxy Pravastatin | Cardiovascular | LC/MS/MS | 0.25-100 ng/mL; 0.25-50ng/mL | Human EDTA Plasma |
| Pravastatin; 3-a-hydroxy Pravastatin | Cardiovascular | LC/MS/MS | 0.25-100 ng/mL ; 0.25-50 ng/mL | Human Lithium Heparinized Plasma |
| Prednisolone | Ophtalmic | LC/MS/MS | 1-500ng/mL | Human ETDA K3 Plasma |
| Prednisolone | Ophtalmic | LC/MS/MS | 1-100 ng/mL | Rat Plasma |
| Prednisone; Prednisolone | Immunology | LC/MS/MS | 1-50 ng/mL; 5-250 ng/mL | Rabbit K3 EDTA Plasma |
| Prednisone; Prednisolone | Immunology | LC-MS/MS | 1-50 ng/ml; 5-250 ng/ml | Human EDTA Plasma |
| Pregabalin | Central Nervous System Agents | LC/MS/MS | 30.07-15036 ng/mL | Human EDTA Plasma |
| Primidone | Central Nervous System Agents | LC/MS/MS | 20-2000 ng/mL | Human EDTA Plasma |
| Progesterone | Endocrinology | RIA | 100-40000 pg/mL | Human Serum |
| Progesterone | Endocrinology | LC/MS/MS | 100-50000 pg/mL | Human EDTA Plasma |
| Promethazine | Respiratory, Gastrointestinal | LC/MS/MS | 0.5-20 ng/mL | Human EDTA Plasma |
| Propanolol Total; 4-Hydroxypropanolol | Cardiovascular | LC/MS/MS | 0.5-100 ng/mL | Human EDTA Plasma |
| Propofol | Central Nervous System Agents | LC/MS | 5-3000 ng/mL | Human Whole Blood |
| Propranolol Total | Cardiovascular | LC/MS/MS | 1-400 ng/mL | Human EDTA Plasma |
| Propranolol Total; 4-hydroxypropranolol | Cardiovascular | LC/MS/MS | 2-400 ng/mL; 0.5-100 ng/mL | Human EDTA Plasma |
| Propylene glycol | Miscellaneous | LC/MS/MS | 1-500 ug/mL | Human Plasma |
| Pseudoephedrine | Respiratory | LC/MS/MS | 6-600 ng/mL | Human EDTA Plasma |
| Pseudoephedrine | Respiratory | LC/MS/MS | 0.2-100 ng/mL | Human Plasma |
| Pseudoephedrine | Respiratory | LC/MS | 5-500 ng/mL | Human EDTA Plasma |
| Pyridoxal | Miscellaneous | LC/MS/MS | 10-400 ng/mL | Human Whole Blood |
| Pyridoxal-5-Phosphate | Miscellaneous | LC/MS/MS | 2-100 ng/mL | Human Plasma |
| Pyridoxamine | Miscellaneous | LC/MS/MS | 200-50000 pg/mL | Human Blood |
| Pyridoxamine | Miscellaneous | LC/MS/MS | 200-50000 pg/mL | Human Plasma |
| Pyridoxamine 5-phosphate | Miscellaneous | LC/MS/MS | 500-50000 pg/mL | Human Blood |
| Pyridoxine | Miscellaneous | LC/MS/MS | 1-200 ng/mL | Human Plasma |